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Introduction {#sec001}
============

Human Papillomavirus (HPV) is the most common cause of sexually transmitted diseases and causes a wide range of pathologies \[[@pone.0157432.ref001], [@pone.0157432.ref002]\]. Although the majority of HPV infections are asymptomatic and self-limiting, the persistent infection with a high-risk HPV (HR-HPV) may cause precancerous lesions that can progress to cancer \[[@pone.0157432.ref001], [@pone.0157432.ref003], [@pone.0157432.ref004]\].

In the 1980s, the link between cervical cancer (CC) and HPV was established \[[@pone.0157432.ref005]\]. During the 1990s, the causal role of HPV was established and accounts worldwide for almost 99% of CC \[[@pone.0157432.ref004]--[@pone.0157432.ref008]\]. Two vaccines are currently available (Bivalent (HPV16/18 and Quadrivalent HPV6/11/16/18) to protect from HR-HPV-16 and 18 with a good safety and efficacy and a cross-protection against other common HR- HPV types \[[@pone.0157432.ref002], [@pone.0157432.ref009]--[@pone.0157432.ref011]\]. These vaccines have been widely introduced into the national immunization programs in most medium and high- income countries \[[@pone.0157432.ref002], [@pone.0157432.ref012]\].

In Tunisia CC is the third cause of cancer in women resulting in an estimated 1,000 deaths per year often in young women \[[@pone.0157432.ref013]\]. It represents a major health problem where national screening programs have not shown efficiency \[[@pone.0157432.ref014]\]. Whereas both vaccines are available in Tunisia, they have not yet been included in the national vaccination program. Such a decision should be informed by estimates of the national HPV prevalence data and a better understanding of the main circulating strains. Three previous Tunisian studies are available reporting different estimates due to differences in the participant recruitment methods, regional variability, and differences in detection tests \[[@pone.0157432.ref015]--[@pone.0157432.ref018]\]. To our knowledge, no national -based study has previously been conducted in our country.

The present study is a part of a national pilot study. It aims to estimate the prevalence and distribution of HPV genotypes and identify related risk factors among women in the Grand-Tunis region (the capital and main surroundings).

Materials and Methods {#sec002}
=====================

Study Population {#sec003}
----------------

A cross-sectional descriptive study was conducted between December 2012 and May 2013. Eligible women were those aged 18 to 65 years old, sexually active resident in the Grand Tunis region, seeking medical attention at their local healthcare centre (CSB) or at a regional reproductive health centre (CRSR) and who gave written consent. The two health centres are considered as a first line healthcare in Tunisia. Selection of CSBs and CRSRs was made proportionally to the size of the governorates between December 2012 and May 2013. As shown in [Fig 1](#pone.0157432.g001){ref-type="fig"}, the Grand Tunis region contains four governorates: Tunis, Ariana, Mannouba and Ben Arous.

![Map showing the 4 governorates of the Grand Tunis region.](pone.0157432.g001){#pone.0157432.g001}

The sample size (n) was calculated for each governorate ([Table 1](#pone.0157432.t001){ref-type="table"}) using the formula for a simple random sample: ($n = DE\left( {Z_{\frac{\alpha}{2^{2}}}\mspace{6mu} p\frac{\left( {1 - p} \right)}{d^{2}}} \right)$) with a 2% accuracy (d = 2%), an 8% estimated HPV infection prevalence as shown in previous Tunisian studies \[[@pone.0157432.ref017],[@pone.0157432.ref018]\], an α error risk of 5% ($Z_{\frac{\alpha}{2} = 1.96}$) and a correction factor of dE = 1.5.

10.1371/journal.pone.0157432.t001

###### Sample size of each governorate included in the study.
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              TUNIS     ARIANA   BEN AROUS   MANOUBA   Total   
  ----------- --------- -------- ----------- --------- ------- -----
              **CSB**   78       44          49        34      205
  **CRSR**    75        36       45          30        186     
  **Total**   153       80       94          64        391     

Data and sample collection {#sec004}
--------------------------

Properly trained medical doctors and midwives conducted face-to-face interviews using a standardized questionnaire, collecting information on socio-demographic status, sexual behaviour of the woman and her partner, reproductive and socio-economic status and medical history. For all women who provided written informed consent, a liquid-based cervical sample was obtained using a cervix brush (Cervexbrush, Easyfix solution Labonord, Templemars, France). Samples were kept at 4°C and sent to the Laboratory of Human and Experimental Pathology at the Pasteur Institute of Tunis (which is the EMRO WHO HPV Reference LabnetLaboratory) in less than one week. Part of the sample was used for a Pap smear and the remaining content stored at -20 C for further use in genomic DNA extraction.

Cytological Diagnosis {#sec005}
---------------------

Cytological diagnosis was performed blindly by two pathologists of the laboratory of Human and Experimental Pathology at the Pasteur Institute and the final conclusion was taken by consensus according to the 2001 Bethesda system \[[@pone.0157432.ref019]\].

DNA extraction {#sec006}
--------------

DNA was extracted from a 200μl aliquot of the suspended cell samples using the QIAamp DNA Blood Mini Kit (Qiagen) according to the manufacturer's instructions. The quality of extracted DNA was evaluated by betaglobin-specific primers PC04/GH20. Only samples positive for betaglobin were further analysed for HPV detection and genotyping.

HPV detection {#sec007}
-------------

HPV was detected using nested PCR with biotinylated PGMY09/11 primers for the first PCR and GP5+/GP6+ primers for the second PCR. Briefly, 50μl mixture containing 3mM MgCl2, 10 μmol of each primer, 1.5 mM of dNTP (dATP, dCTP, TTP, dGTP), 5μl of the Taq DNA polymerase buffer, 1U of Taq DNA Polymerase, and 10 μl of DNA preparation was aliquoted. The PCR cycling parameters were composed of a 10 minutes initial denaturation at 94°C, followed by 30 amplification cycles of 30 s at 94°C, 1 min at 50°C and 1 min at 72°C, and a final extension step for 7 minutes at 72°C. This reaction was followed by a nested PCR using 10μl of the PGMY PCR product in a reaction mixture containing 50 μmol of GP5+/GP6+ primers, 3mM MgCl2, 1.5 mM each of the dNTP, 1U of Taq DNA Polymerase and 5μl of the Taq DNA polymerase buffer. The PCR cycling parameters comprised of a 10 minutes initial denaturation at 94°C, followed by 40 amplification cycles of 1 minutes at 94°C, 2 minutes at 40°C and 1.5 minute at 72°C, and a final extension step for 7 minutes at 72°C.

HPV genotyping {#sec008}
--------------

Genotyping of positive samples was performed by Reverse Line Hybridization as described in the Human Papillomavirus Laboratory Manual published by the World Health Organization \[[@pone.0157432.ref020]\]. Briefly, 15μL of denatured PCR products were allowed to hybridize with oligonucleotide probes specific for 31 HPV types (HPV6, 11, 16, 18, 26, 31, 33, 34, 35, 39, 40, 42, 44, 45, 51, 52, 53, 54, 55, 56, 57, 58, 59, 66, 68, 69, 70, 73, 82, 83, and 84) that were immobilized on a Biodyne C membrane using the Miniblotter MN45. The hybridized DNA was detected using Streptavidin peroxydase and Enhanced chemiluminiscent ECL®.

Statistical analysis {#sec009}
--------------------

Qualitative variables were described by the simple counts and percentages; quantitative variables by the mean ± SEM. The distribution of HPV genotypes was summarized using frequency distributions. The relation of HPV positivity with demographic, epidemiological and clinical differences was first examined by univariate analysis using the two-sample t test for normally distributed continuous data, the Mann-Whitney test for non-parametric data, the chi-squared test for frequencies and the Fisher's test and the chi-square test for trend. Odds Ratios (ORs) and 95% confidence intervals (CI) were used to quantify the association between risk factors and positivity for HPV. Multivariable analysis was done using multiple logistic regression to study the relationship between HPV infection (HPV-positive vs. HPV-negative) and the explanatory variables, while adjusting for confounding factors and effect modification if needed. Model building was done using backward procedures. Only variables that retained statistically significant associations with the outcome variables were left in multivariate analyses. A p-value \<0.05 was considered statistically significant. Data analysis was performed using SPSS version 22 software.

Ethical considerations {#sec010}
----------------------

The study was approved by the Ethics Committee of Institut Pasteur de Tunis and conducted in accordance with Good Clinical Practice, ensuring confidentiality and anonymity. Written informed consent was obtained prior to enrolment of study participants.

Results {#sec011}
=======

Three hundred ninty-one women were enrolled in this study. Sixty-six out of 391 samples collected were negative for betaglobin and were excluded. HPV detection and typing were performed on the remaining 325 samples. Of note, no significant differences were observed between excluded women and included women in this study ([S1 Table](#pone.0157432.s001){ref-type="supplementary-material"}).

Socio-demographic characteristics of study population {#sec012}
-----------------------------------------------------

Socio-demographic characteristics of the participants are presented in [Table 2](#pone.0157432.t002){ref-type="table"}. The mean age of participants was 40.7± 0.5 years and 54% were over 40 years old. The majority of the participants were married (95%), 17% had no formal education, 64% were unemployed and only 11% had ever smoked. Median age at first sexual intercourse was 23 years (IQR 20--23) and 27% had multiple sexual partners.

10.1371/journal.pone.0157432.t002

###### Characteristics of the studied women in the Grand Tunis region, Tunisia.
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                                                         N          \%
  ------------------------------------------------------ ---------- -------
  **Age group (years)**                                             
  \< = 30                                                35         10.8%
  \[30--40\[                                             115        35.5%
  \[40--50\[                                             127        39.2%
  \>50                                                   47         14.5%
  **Governorate**                                                   
  Tunis                                                  127        39.4%
  Ariana                                                 70         20.6%
  Ben Arous                                              81         25.5%
  Mannouba                                               47         14.5%
  **Marital status**                                                
  Married                                                308        94.8%
  Widowed, divorced, separated, never married            17         5.2%
  **Level of education**                                            
  Illiterate                                             56         17.2%
  Primary level                                          164        50.5%
  Secondary and high level                               105        32.3%
  **Smoking**                                                       
  Yes                                                    37         11.4%
  No                                                     287        88.6%
  **Mean age at sexual intercourse debut (years ±SD)**   24.1±5.7   
  **Mean number of sexual partners**                     1.7±7.0    

HPV prevalence and HPV genotype {#sec013}
-------------------------------

HPV prevalence in 325 cases was 13.2% (95% CI, 9.8%-17.5%). Prevalence of HPV infection according to socio-demographic, clinical and behaviour characteristics is summarised in [Table 3](#pone.0157432.t003){ref-type="table"}.

10.1371/journal.pone.0157432.t003

###### HPV Prevalence by socio-demographic characteristics, medical history and behaviour.
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  Demographic Characteristic                      Sample Size   HPV Prevalence \[95% CI\]   P value
  ----------------------------------------------- ------------- --------------------------- ----------
  **Overall Age**                                 324           13.2% \[9.8%-17.5%\]        
  **Center**                                                                                
  CSB                                             27            62.8%\[55.6%-70%\]          0.126
  CRSR                                            16            37.2%\[29.5%-44.9%\]        
  **Age group (years)**                                                                     
  \< = 30                                         35            20.0% \[10.4%-33.7%\]       0.45
  \[30--40\[                                      115           12.2% \[7.5%-18.6%\]        
  \[40--50\[                                      127           11.0% \[6.8%-16.9%\]        
  \>50                                            47            17.0% \[9.2%-28.3%\]        
  **Governorate**                                                                           
  Tunis                                           127           9.4 \[5.6%-15.0%\]          0.34
  Ariana                                          70            12.9 \[7.0%-21.3%\]         
  Ben Arous                                       81            17.3 \[10.8%-25.9%\]        
  Mannouba                                        47            17.0 \[9.2%-28.3%\]         
  **Education level**                                                                       
  Illiterate                                      56            12.5 \[6.4%-21.9%\]         0.17
  Primary level                                   164           16.5 \[11.7%-22.4%\]        
  Secondary and high level                        105           8.6 \[4.7%-14.5%\]          
  **Marital status**                                                                        
  Married                                         308           11.0% \[8.0%-14.7%\]        \<10^−3^
  Widowed, divorced, separated, never married     17            52.9%\[32.9%-72.2%\]        
  **Income Index**                                                                          
  Below Poverty                                   74            6.8% \[3.0%-13.3%\]         0.15
  Above Poverty Intermediate Index                136           13.2% \[8.7%-19.3%\]        
  Above Poverty High Index                        89            16.9% \[10.7%-25.0%\]       
  **Housing Type**                                                                          
  Good                                            97            18.6% \[12.2%-26.6%\]       0.07
  Bad                                             226           11.1% \[8.0%-15.9%\]        
  **Occupation**                                                                            
  unemployed                                      207           11.1% \[7.6%-15.7%\]        0.11
  With regular job                                115           17.4% \[11.7%-24.6%\]       
  **Tobacco use**                                                                           
  Yes                                             37            29.7%\[18.0%-44.1%\]        0.02
  No                                              287           11.1%\[8.1%-15.0%\]         
  **Menopause**                                                                             
  Yes                                             51            15.7% \[8.4%-26.3%\]        0.6
  No                                              274           12.8% \[9.4%-16.9%\]        
  **Pregnancy**                                                                             
  Yes                                             9             33.3% \[13.7%-66.0%\]       0.06
  No                                              296           12.2% \[9.0%-16.1%\]        
  **Contraception**                                                                         
  Yes                                             88            14.8% \[9.0%-22.6%\]        0.6
  No                                              231           12.4% \[8.9%-17.0%\]        
  **Medical history of chronic disease**                                                    
  Yes                                             102           10.8%\[6.3%-17.3%\]         0.4
  No                                              223           14.3%\[10.4%-19.2%\]        
  **Surgical history**                                                                      
  Yes                                             126           15.1%\[10.0--21.6%\]        0.4
  No                                              198           12.1%\[8.3%-16.9%\]         
  **casual sexual relation the last 12 months**                                             
  Yes                                             12            50.0%\[27.7%-72.3%\]        \<10^−3^
  No                                              288           11.5%\[8.3%-15.3%\]         
  **Sexually transmitted infection history**                                                
  Yes                                             87            16.1%\[10.0%-24.2%\]        0.35
  No                                              238           12.2%\[8.7%-16.6%\]         
  **Multiple sexual intercourse of partner**                                                
  Yes                                             29            31.0% \[17.9%-47.3%\]       0.001
  No                                              277           10.5% \[9.1%-17.3%\]        
  **age at first sexual intercourse**                                                       
  ≤ 18 years                                      39            20.5% \[17.8%-24.0%\]       0.13
  \>18 years                                      286           12.2% \[11.2%-13.5%\]       
  **Multiple sexual partners**                                                              
  Yes                                             18            33.3% \[29.1%-38.4%\]       0.015
  No                                              236           11.0% \[10.0%-12.3%\]       

The prevalence of HR-HPV and low-risk HPV (LR-HPV) types were 3.1% (95% CI, 1.5%-5.2%) and 6.5% (95% CI, 4.0%-9.5%), respectively. Multiple infections were detected in only 18% of positive samples (8/43) and single infections in 55.8% (24/43). Of the 8 multiple HPV infected samples, 5 were infected with 2 HPV types, 2 were infected with 3 HPV types, and 1 was infected with 4 HPV types. Multiple infections with both HR-HPV and LR-HPV types were the most common (62.5%). mixed infections with HR-HPVs were observed in 25% of cases while mixed infections with LR-HPVs were seen in 12.5% of cases. The most common HR-HPVs were HPV16 (1.2%; 95% CI, 1.0%-1.6%), HPV31 and HPV52 (0.9%; 95% CI, 0.8%-1.2%). HPV6 (5.2%; 95% CI, 4.6%-6.0%) and HPV40 (2.5%; 95% CI, 2.1%-3.0%) were the most common in LR-HPV. The prevalence of detected HPV types is shown in [Fig 2](#pone.0157432.g002){ref-type="fig"}.

![HPV Type prevalence in Grand Tunis Region.](pone.0157432.g002){#pone.0157432.g002}

### HPV distribution according to age {#sec014}

Prevalence of HPV infection was highest among women aged less than 30 years (20%; 95% CI, 10.4%-33.7%), followed by a non-significant decline in HPV prevalence in women aged 30 to 50 years and a new increase after 50 years of age (p = 0.45). There was a statistically significant difference between low- and high-risk HPV prevalence trends by age ([Fig 3](#pone.0157432.g003){ref-type="fig"}). Prevalence of HR-HPV types increased significantly with age (p = 0.04), while this was not the case with LR-HPV prevalence (p = 0.8) as showed in [Fig 3](#pone.0157432.g003){ref-type="fig"}.

![HPV prevalence according to age groups.](pone.0157432.g003){#pone.0157432.g003}

The distribution of detected genotypes according to age groups showed that HPV 16 was the most common type in women aged 31--40 and over 50 years-old. HPV31 was present in all age groups except in women aged 41--50 year. Here HPV6, HPV40, and HPV35 were the major genotypes ([Table 4](#pone.0157432.t004){ref-type="table"}).

10.1371/journal.pone.0157432.t004

###### HPV type distribution according to age groups.
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              Age groups                     
  ----------- ------------ -------- -------- --------
  **HPV6**    11,8%        41,2%    35,3%    11,8%
  **HPV40**   37,5%        25,0%    25,0%    12,5%
  **HPV55**   0,0%         0,0%     0,0%     100,0%
  **HPV70**   0,0%         0,0%     100,0%   0,0%
  **HPV16**   0,0%         50,0%    0,0%     50,0%
  **HPV31**   33,3%        33,3%    0,0%     33,3%
  **HPV35**   0,0%         0,0%     100,0%   0,0%
  **HPV39**   0,0%         100,0%   0,0%     0,0%
  **HPV52**   33,3%        33,3%    0,0%     33,3%
  **HPV53**   0,0%         100,0%   0,0%     0,0%
  **HPV59**   0,0%         50,0%    0,0%     50,0%
  **HPV68**   0,0%         0,0%     100,0%   0,0%
  **HPV89**   0,0%         0,0%     100,0%   0,0%
  **HPV66**   0,0%         0,0%     100,0%   0,0%

### HPV distribution according to cytology {#sec015}

A total of 27 (8.3%) cervical cytology samples were inadequate. For those with adequate results, Pap smear was normal for 115 women (35.4%, 95% CI, 33.4%-44.4%). It was atrophic or inflammatory for 141 women (43.4%, 95% CI, 41.9%-52.8%), Low-squamous intraepithelial lesions (LSIL) were seen for 38 women (11.7%, 95% CI, 9.5%-16.7%) and High-squamous intraepithelial lesion (HSIL) and Atypical glandular undetermined significance (AGUS) accounted for two cases (0.6%, 95% CI, 0.2%-1.9%). HPV prevalence was 16.5% (95% CI, 11.0%-23.6%) in normal smear, 10.6% (95% CI, 6.6%-16.1%) in atrophic or inflammatory smears and 18.4% (95% CI, 9.6%-31.3%) in LSIL. HPV infection in HSIL accounted for 50% of cases and all were single HPV31 infections. The 2 cases of AGUS were HPV negative.

Risk factors for HPV infection {#sec016}
------------------------------

Associated factors with HPV infection in univariate analysis were marital status, tobacco use, sexual behaviour and partner sexual behaviour ([Table 5](#pone.0157432.t005){ref-type="table"}).

10.1371/journal.pone.0157432.t005

###### Univariate analysis of associated factors with HPV infection.
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  Characteristic                                                       OR \[95% CI\]         P value[\*](#t005fn001){ref-type="table-fn"}
  -------------------------------------------------------------------- --------------------- ----------------------------------------------
  ***Marital status***                                                                       
  Married                                                              Ref                   
  Widowed, divorced, separated, never married                          6.9 \[1.1--42.2\]     \<10^−3^
  ***Income Index***                                                                         
  Below Poverty Index                                                  Ref                   
  Above Poverty Intermediate Index                                     9.6 \[1.4--63.4\]     0.019
  Above Poverty high Index                                             22.1 \[2.8--175.5\]   0.003
  ***Housing Type***                                                                         
  Good                                                                 Ref                   
  Bad                                                                  2.5 \[1--6.8\]        0.05
  ***Smoking***                                                                              
  Yes                                                                  2.8 \[0.8--9.6\]      0.003
  No                                                                   Ref                   
  ***Partner with multiple sexual encounters outside relationship***                         
  Yes                                                                  4.5 \[0.9--22.9\]     0.07
  No                                                                                         
  ***Age at sexual intercourse debut***                                                      
  ≤ 18 years                                                           2.7 \[0.8--9.5\]      0.12
  \>18 years                                                           Ref                   

\* χ2 Wald

Multivariate analysis suggests that marital status, partner with multiple sexual encounters outside the stable relationship, housing type and income index were independently associated with HPV infection ([Table 6](#pone.0157432.t006){ref-type="table"}). However, the age at sexual intercourse debut and the increasing number of sexual encounters of the partner were not significant in the multivariate model.

10.1371/journal.pone.0157432.t006

###### Multivariable analysis of associated factors with HPV infection (N = 219).
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  Characteristic                                                       AOR \[95% CI\]        P value[\*](#t006fn001){ref-type="table-fn"}
  -------------------------------------------------------------------- --------------------- ----------------------------------------------
  ***Marital status***                                                                       
  Married                                                              Ref                   
  Widowed, divorced, separated, never married                          6.9 \[1.1--42.2\]     \<10^−3^
  ***Income Index***                                                                         
  Below Poverty Index                                                  Ref                   
  Above Poverty Intermediate Index                                     9.6 \[1.4--63.4\]     0.019
  Above Poverty high Index                                             22.1 \[2.8--175.5\]   0.003
  ***Housing Type***                                                                         
  Good                                                                 Ref                   
  Bad                                                                  2.5 \[1--6.8\]        0.05
  ***Smoking***                                                                              
  Yes                                                                  2.8 \[0.8--9.6\]      0.003
  No                                                                   Ref                   
  ***Partner with multiple sexual encounters outside relationship***                         
  Yes                                                                  4.5 \[0.9--22.9\]     0.07
  No                                                                                         
  ***Age at sexual intercourse debut***                                                      
  ≤ 18 years                                                           2.7 \[0.8--9.5\]      0.12
  \>18 years                                                           Ref                   

\* χ2 Wald

Discussion {#sec017}
==========

Baseline information on HPV prevalence and genotype distribution is crucial to evaluate the impact of HPV vaccines and inform the best approach for cervical cancer prevention. Our cross-sectional study estimated HPV prevalence in women residing in the Grand Tunis region and is a part of the first large-scale national-based epidemiological study on the prevalence of HPV infection and genotype distribution.

In this study, the prevalence of HPV infection in the Grand Tunis region was estimated as 13.2%. The few previous studies in Tunisia that focused on a small series of participants in cervical screening programs have shown divergent results, that is 43.8% among Tunisian female prostitutes \[[@pone.0157432.ref016]\], 7.8% in the reproductive health centre of Ariana \[[@pone.0157432.ref017]\] and 6.5% in Urban Tunis region \[[@pone.0157432.ref018]\]. Heterogeneity with regards to the methods for participant selection and the representativeness in the population and the lack of epidemiological and behavioural data make any comparison with the current study findings difficult. Several meta-analyses \[[@pone.0157432.ref021]--[@pone.0157432.ref023]\] confirmed that HPV infection varied by geographical area, age, life style and socio-economic status. Difference in HPV prevalence might also partly be attributed to the difference in sample population and methods used. The HPV prevalence estimated in our study is similar to that reported in a study in Morocco \[[@pone.0157432.ref024]\], but higher than that reported in other North African countries, namely 6.3% in Algeria \[[@pone.0157432.ref025]\] and 10.3% in Egypt \[[@pone.0157432.ref026]\].

In this study, HR-HPV accounted for about half of all HPV infections, with the most prevalent HR-HPV being HPV-16, 31, 52 and 59. Comparing with reported series, HPV16 was the most common genotype \[[@pone.0157432.ref024], [@pone.0157432.ref025],[@pone.0157432.ref026]\] and HPV52 and 31 were the second most common genotypes in Africa and Europe, respectively \[[@pone.0157432.ref021]--[@pone.0157432.ref023]\]. Of note, HPV18 the second most frequently detected HR-HPV worldwide \[[@pone.0157432.ref021]--[@pone.0157432.ref023]\] was surprisingly scarce in our study population. In our study, almost four per cent of the samples could not be genotyped. This may be due to the fact that some samples had low viral load and/or some HPV types were not included in the tested probes \[[@pone.0157432.ref027]\].

Two peaks of infection by age appear clearly in our results. One peak in ages less than 30 years, which could represent the beginning of sexual activity, and another peak in ages greater than 50 years. This second peak may partly be explained by a relative lack of viral clearance and insufficient adaptive immune responses at this age caused by hormonal changes, contributing to HPV persistence or reactivation of latent HPV infections \[[@pone.0157432.ref028]--[@pone.0157432.ref031]\]. Our results were consistent with the meta-analysis conducted by Bruni et al. \[[@pone.0157432.ref022]\] wherein the age distribution of cervical HPV infection showed a bimodal curve with a first peak at younger ages (\<25 years), that is just after sexual intercourse debut, a low prevalence plateau within the middle age groups (30--40 years), and a rebound at older ages (\>45 years). Previous studies showed that the prevalence of multiple HPV infection was the highest in the oldest age group \[[@pone.0157432.ref032]--[@pone.0157432.ref033]\]. A possible explanation is that the immune response to HPV infection in older women is relatively low, and immunomodulation of the virus is suppressed \[[@pone.0157432.ref030]--[@pone.0157432.ref034]\]. These results indicate that women in the young and old age group need more clinical surveillance and management of HPV infection.

In this study HPV infection in normal Pap smears accounted for 16.5% (95% CI, 11.0%-23.6%). This prevalence is similar to reported series in Africa (7.3%-37.1%), America (4.6%-42.2%) and Europe (8.5%-22.7%) \[[@pone.0157432.ref022]\].

In our study, risk factors were shown to be specific: the better the income, the greater the risk of HPV infection. Several risk factors related to HPV infection and persistence, such as age, smoking, age at first sexual relation and multiple sexual partners, are reported in the world with differences due to the specificities of each studied population \[[@pone.0157432.ref001], [@pone.0157432.ref023], [@pone.0157432.ref025], [@pone.0157432.ref029]\]. In contradiction with our data, low-income level increases the risk of HPV infection, probably related to lack of access to proper care, which facilitates infection and persistence of HPV and an increasing risk of turning into cancer \[[@pone.0157432.ref035]--[@pone.0157432.ref037]\].

It is established that smoking increases the risk of HPV infection and persistence through a vulnerability of immune system which facilitates infection and persistence of HPV and an increasing risk of turning into cancer \[[@pone.0157432.ref038]\]. In our study, current smokers seem to be almost three times more at risk of getting HPV infection compared to non-smokers. However, the association is not significant, probably due to lack of power of a limited sample size. In the literature, it has been shown that smoking was associated with an increased prevalence of HPV \[[@pone.0157432.ref029], [@pone.0157432.ref038]--[@pone.0157432.ref040]\].

Various aspects of sexual behaviour were reported to be related to the acquisition of HPV infection \[[@pone.0157432.ref023], [@pone.0157432.ref029], [@pone.0157432.ref040]\]. In the present study, the marital status appears as a factor associated with HPV infection. Single or divorced women are more often infected than married ones (52.9% versus 11%). This could be explained by a different way of life that could lead them to have more than one sexual partner \[[@pone.0157432.ref040]\]. However, unlike previous studies \[[@pone.0157432.ref040]--[@pone.0157432.ref042]\], neither age at the first intercourse nor the number of sexual partner, were significantly associated with HPV infection. These findings need to be considered in light of the extremely sensitive nature of this question and possible inaccurate answer, leading to exposure misclassification bias.

Conclusion {#sec018}
==========

HPV infection prevalence in the Grand Tunis region was 13.2% and is larger than previous estimates in Tunisia. HR-HPV types accounted for half of all infections and were mainly HPV-16, 31, 52 and 59. Smoking, sexual behaviour of partner and high level income were the main risk factors. This study is the pilot phase of a national survey which aims to assess the national HPV prevalence in the whole of Tunisia and provide baseline data to enhance the understanding of HPV infection. Those findings will inform recommendations to optimize HPV screening efforts for high-risk genotypes, the most affected age groups and to evaluate the cost-effectiveness of vaccine program implementation in Tunisia in future.
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###### Comparaison between betaglobin positive and betaglobin negative samples.

(DOC)

###### 

Click here for additional data file.
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